<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02513693</url>
  </required_header>
  <id_info>
    <org_study_id>IGA_LF_2015_012</org_study_id>
    <nct_id>NCT02513693</nct_id>
  </id_info>
  <brief_title>Deep Neuromuscular Blockade During Robotic Radical Prostatectomy</brief_title>
  <official_title>Effect of Deep Neuromuscular Blockade on Surgical Conditions and Recovery After Robotic Radical Prostatectomy: a Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Palacky University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Olomouc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Masaryk Hospital Usti nad Labem</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Palacky University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Basic requirement for safe performance of the robotic intra-abdominal surgery is a calm and
      clear surgical field after the introduction of a capnoperitoneum. That can be enabled by a
      neuromuscular blockade. Provision of standard neuromuscular blockade is a compromise between
      optimal surgical conditions (sufficiently deep block) and capability to antagonize the block
      rapidly at the end of the surgery. With rocuronium, it is possible to maintain deep
      neuromuscular blockade safely until the very end of the surgery, and unlike with spontaneous
      recovery or reversal of the block with neostigmine, administration of sugammadex at the end
      of the surgery will enable quick and consistent reversal of the block. Project is focused on
      comparison of the parameters of deep and standard neuromuscular blockade - surgical
      conditions (primary endpoint), quality of recovery and turnover time (secondary endpoints).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Balanced anesthesia is an anesthetic procedure of choice for intra-abdominal surgery. Main
      components of this procedure are loss of consciousness, treatment of pain and appropriate
      neuromuscular blockade (NMB). Peripheral neuromuscular blocking agents (NMBA) are drugs used
      for muscle relaxation during balanced anesthesia. Their use plays essential role for tracheal
      intubation, orotracheal tube tolerance, introduction of mechanical ventilation and provision
      of calm surgical field.

      In laparoscopic procedures, introduction of capnoperitoneum for good visibility in surgical
      field is necessary. From anesthetic point of view this requirement can be met by adequate
      muscle relaxation. After withdrawal of capnoperitoneum at the end of the surgery the
      procedure is usually terminated quickly (this phase consists only from suture of a peritoneum
      and the small incisions through which instruments were inserted). Spontaneous recovery from
      NMB or usual reversal of the block by neostigmine are not fast and reliable enough at this
      moment. During standard neuromuscular blockade the dosage of NMBA is a compromise between
      optimal surgical conditions (sufficiently deep block) and capability to antagonize the block
      rapidly at the end of the surgery. Introduction of sugammadex into clinical praxis brings the
      potential to change this paradigm. With rocuronium, it is possible to maintain deep
      neuromuscular blockade safely until the very end of the surgery and unlike with spontaneous
      recovery or reversal of the block with neostigmine, administration of sugammadex at the end
      of the surgery will enable quick and consistent reversal of the block. Data about routine use
      of the deep block are rare, PubMed lists with search strategy [(deep neuromuscular blockade)
      AND (laparoscopic surgery OR laparoscopy)] 11 references (January 12, 2015, www.pubmed.com).

      Patients undergoing robotic radical prostatectomy will be randomized to two groups differing
      in muscle relaxation strategy (standard vs. deep) and the type of antagonizing drug at the
      end of the surgery (neostigmine vs. sugammadex). Relevant end-points and the differences
      between groups with deep and standard neuromuscular blockade will be compared. Indication and
      dosage of rocuronium, neostigmine and sugammadex correspond to manufacturers'
      recommendations.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Surgical condition</measure>
    <time_frame>Every 15 minutes during surgery until final suture</time_frame>
    <description>Surgical rating score (SRS) - surgical condition will be evaluated by surgeon every 15 minutes on predefined five point scale (excellent - above average - average - below average - poor). For each patient, the final score will be the average of all 15 min SRS values.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of recovery</measure>
    <time_frame>2 months</time_frame>
    <description>Speed of clinical recovery by using Post-Operative Quality Recovery Scale (www.pqrsonline.org). PQRS will be evaluated at following time points:
preoperatively, day (D) 1, D3, D7, month (M) 1, M2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>&quot;Ready to leave operating room (OR)&quot; time</measure>
    <time_frame>Period of patient's presence at OR</time_frame>
    <description>&quot;Ready to leave OR time&quot; will be defined as a time period (in minutes) from the time point of completing surgery to the time point, when patient is ready to leave OR to the facility providing postanesthesia care.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Standard Neuromuscular Blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: rocuronium + neostigmine
Administration of rocuronium 0,6 mg/kg iv, top-ups 5-10 mg iv to target value of Train-of-Four (TOF) count = 1-2, TOF-count measurement every 1 min. Neuromuscular blockade reversal at the end of anesthesia: neostigmine 0.03 mg/kg iv + atropine 0.5-1.0 mg iv Induction of anesthesia: midazolam 1-2 mg iv, sufentanil 10-30 mcg iv, propofol 1.5-2.5 mg/kg iv Anesthesia: sevoflurane in air to target 1.2-1.5 minimal alveolar concentration (MAC). Rescue medication: sevoflurane, propofol 20-40 mg iv Extubation when patient is conscious and attained the recovery from neuromuscular blockade to a TOF-ratio of at least 0,9.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Deep Neuromuscular Blockade</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: rocuronium + sugammadex
Administration of rocuronium 0,6 mg/kg iv, top-ups 5-10 mg iv to target value of Post-tetanic Count (PTC) = 1-2; PTC measurement every 4 min. Neuromuscular blockade reversal at the end of anesthesia: sugammadex 2 mg/kg iv (when PTC is 18-20 and TOF-count 0) or sugammadex 4 mg/kg iv (when PTC under 18).
Induction of anesthesia: midazolam 1-2 mg iv, sufentanil 10-30 mcg iv, propofol 1,5-2,5 mg/kg iv Anesthesia: sevoflurane in air to target 1.2-1.5 minimal alveolar concentration (MAC). Rescue medication: sevoflurane, propofol 20-40 mg iv.
Extubation when patient is conscious and attained recovery from neuromuscular blockade to a TOF-ratio of at least 0,9.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard neuromuscular blockade</intervention_name>
    <description>Standard neuromuscular block provided by rocuronium to TOF-count 1-2. Reversal of the block with neostigmine.</description>
    <arm_group_label>Standard Neuromuscular Blockade</arm_group_label>
    <other_name>Rocuronium + neostigmine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Deep neuromuscular blockade</intervention_name>
    <description>Deep neuromuscular block provided by rocuronium to PTC 1-2. Reversal of the block with sugammadex.</description>
    <arm_group_label>Deep Neuromuscular Blockade</arm_group_label>
    <other_name>Rocuronium + sugammadex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years

          -  Informed consent

          -  Elective robotic radical prostatectomy

          -  American Society of Anesthesiologists (ASA) status 1-3

        Exclusion Criteria:

          -  Age under 18 years

          -  American Society of Anesthesiologists (ASA) status over 3

          -  Indication for rapid sequence induction, signs of difficult airway severe
             neuromuscular, liver or renal disease

          -  Known allergy to drugs used in the study

          -  Malignant hyperthermia (medical history)
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Milan Adamus, MD,PhD,MBA</last_name>
    <role>Study Director</role>
    <affiliation>Department of Anesthesiology and Intensive Care Medicine Palacky University Olomouc Faculty of Medicine and Dentistry</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vladimir Cerny, MD,PhD,FCCM</last_name>
    <role>Principal Investigator</role>
    <affiliation>J. E. Purkinje University, Masaryk Hospital, Usti nad Labem, Czech Republic, Dept. of Anesthesiology, Perioperative Medicine and Intensive Care</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Milan Adamus, MD,PhD,MBA</last_name>
    <phone>+420588442705</phone>
    <email>milan.adamus@seznam.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lenka Doubravská, MD</last_name>
    <phone>+420588445979</phone>
    <email>lenadoub@seznam.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. of Anesthesiology and Intensive Care Medicine, University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milan Adamus, MD,PhD,MBA</last_name>
      <phone>+420 588 442 705</phone>
      <email>milan.adamus@seznam.cz</email>
    </contact>
    <contact_backup>
      <last_name>Lenka Doubravská, MD</last_name>
      <phone>+420 588 445 979</phone>
      <email>lenadoub@seznam.cz</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Dept. of Anesthesiology, Perioperative Medicine and Intensive Care, J. E. Purkinje University, Masaryk Hospital</name>
      <address>
        <city>Usti nad Labem</city>
        <zip>401 13</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vladimir Cerny, MD,PhD,FCCM</last_name>
      <phone>+420 602 492 054</phone>
      <email>cernyvla1960@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <results_reference>
    <citation>Lindekaer AL, Halvor Springborg H, Istre O. Deep neuromuscular blockade leads to a larger intraabdominal volume during laparoscopy. J Vis Exp. 2013 Jun 25;(76). doi: 10.3791/50045.</citation>
    <PMID>23851450</PMID>
  </results_reference>
  <results_reference>
    <citation>Staehr-Rye AK, Rasmussen LS, Rosenberg J, Juul P, Gätke MR. Optimized surgical space during low-pressure laparoscopy with deep neuromuscular blockade. Dan Med J. 2013 Feb;60(2):A4579.</citation>
    <PMID>23461992</PMID>
  </results_reference>
  <results_reference>
    <citation>Boon M, Martini CH, Aarts LP, Bevers RF, Dahan A. Effect of variations in depth of neuromuscular blockade on rating of surgical conditions by surgeon and anesthesiologist in patients undergoing laparoscopic renal or prostatic surgery (BLISS trial): study protocol for a randomized controlled trial. Trials. 2013 Mar 1;14:63. doi: 10.1186/1745-6215-14-63.</citation>
    <PMID>23452344</PMID>
  </results_reference>
  <results_reference>
    <citation>Ding L, Zhang H, Mi W, Sun L, Zhang X, Ma X, Li H. [Effects of carbon dioxide pneumoperitoneum and steep Trendelenburg positioning on cerebral blood backflow during robotic radical prostatectomy]. Nan Fang Yi Ke Da Xue Xue Bao. 2015 May;35(5):712-5. Chinese.</citation>
    <PMID>26018268</PMID>
  </results_reference>
  <results_reference>
    <citation>Ding L, Zhang H, Mi W, He Y, Zhang X, Ma X, Li H. [Effects of dexmedetomidine on recovery period of anesthesia and postoperative cognitive function after robot-assisted laparoscopicradical prostatectomy in the elderly people]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Feb;40(2):129-35. doi: 10.11817/j.issn.1672-7347.2015.02.003. Chinese.</citation>
    <PMID>25769330</PMID>
  </results_reference>
  <results_reference>
    <citation>Dogra PN, Saini AK, Singh P, Bora G, Nayak B. Extraperitoneal robot-assisted laparoscopic radical prostatectomy: Initial experience. Urol Ann. 2014 Apr;6(2):130-4. doi: 10.4103/0974-7796.130555.</citation>
    <PMID>24833824</PMID>
  </results_reference>
  <results_reference>
    <citation>Kopman AF, Naguib M. Laparoscopic surgery and muscle relaxants: is deep block helpful? Anesth Analg. 2015 Jan;120(1):51-8. doi: 10.1213/ANE.0000000000000471. Review.</citation>
    <PMID>25625254</PMID>
  </results_reference>
  <results_reference>
    <citation>Donati F, Brull SJ. More muscle relaxation does not necessarily mean better surgeons or &quot;the problem of muscle relaxation in surgery&quot;. Anesth Analg. 2014 Nov;119(5):1019-21. doi: 10.1213/ANE.0000000000000429.</citation>
    <PMID>25329018</PMID>
  </results_reference>
  <results_reference>
    <citation>Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth. 2014 Mar;112(3):498-505. doi: 10.1093/bja/aet377. Epub 2013 Nov 15.</citation>
    <PMID>24240315</PMID>
  </results_reference>
  <results_reference>
    <citation>Staehr-Rye AK, Rasmussen LS, Rosenberg J, Juul P, Lindekaer AL, Riber C, Gätke MR. Surgical space conditions during low-pressure laparoscopic cholecystectomy with deep versus moderate neuromuscular blockade: a randomized clinical study. Anesth Analg. 2014 Nov;119(5):1084-92. doi: 10.1213/ANE.0000000000000316. Erratum in: Anesth Analg. 2015 Apr;120(4):957. Dosage error in article text.</citation>
    <PMID>24977638</PMID>
  </results_reference>
  <results_reference>
    <citation>Dubois PE, Putz L, Jamart J, Marotta ML, Gourdin M, Donnez O. Deep neuromuscular block improves surgical conditions during laparoscopic hysterectomy: a randomised controlled trial. Eur J Anaesthesiol. 2014 Aug;31(8):430-6. doi: 10.1097/EJA.0000000000000094.</citation>
    <PMID>24809482</PMID>
  </results_reference>
  <results_reference>
    <citation>Vijayaraghavan N, Sistla SC, Kundra P, Ananthanarayan PH, Karthikeyan VS, Ali SM, Sasi SP, Vikram K. Comparison of standard-pressure and low-pressure pneumoperitoneum in laparoscopic cholecystectomy: a double blinded randomized controlled study. Surg Laparosc Endosc Percutan Tech. 2014 Apr;24(2):127-33. doi: 10.1097/SLE.0b013e3182937980.</citation>
    <PMID>24686347</PMID>
  </results_reference>
  <results_reference>
    <citation>Gurusamy KS, Vaughan J, Davidson BR. Low pressure versus standard pressure pneumoperitoneum in laparoscopic cholecystectomy. Cochrane Database Syst Rev. 2014 Mar 18;(3):CD006930. doi: 10.1002/14651858.CD006930.pub3. Review.</citation>
    <PMID>24639018</PMID>
  </results_reference>
  <results_reference>
    <citation>Royse CF, Newman S, Chung F, Stygall J, McKay RE, Boldt J, Servin FS, Hurtado I, Hannallah R, Yu B, Wilkinson DJ. Development and feasibility of a scale to assess postoperative recovery: the post-operative quality recovery scale. Anesthesiology. 2010 Oct;113(4):892-905. doi: 10.1097/ALN.0b013e3181d960a9.</citation>
    <PMID>20601860</PMID>
  </results_reference>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2015</study_first_submitted>
  <study_first_submitted_qc>July 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 3, 2015</study_first_posted>
  <last_update_submitted>July 30, 2015</last_update_submitted>
  <last_update_submitted_qc>July 30, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 3, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Palacky University</investigator_affiliation>
    <investigator_full_name>Milan Adamus, MD, PhD, MBA</investigator_full_name>
    <investigator_title>Milan Adamus, MD, PhD, MBA</investigator_title>
  </responsible_party>
  <keyword>Anesthesia</keyword>
  <keyword>Rocuronium</keyword>
  <keyword>Sugammadex</keyword>
  <keyword>Neostigmine</keyword>
  <keyword>TOF</keyword>
  <keyword>Radical Prostatectomy</keyword>
  <keyword>Robotic Surgery</keyword>
  <keyword>Accelerometry</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rocuronium</mesh_term>
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

